structural biology

Altoris accelerates therapeutics discovery with intuitive software and analytics for small molecules. It supports biotechnology, pharmaceutical, and academic groups with desktop and enterprise tools developed in close collaboration with customers in complex research environments. Altoris combines proven software with custom development and consulting to help teams move faster from early discovery to preclinical work.

chemoinformaticscustom analytics and integrationmedicinal chemistrymodeling and data workflowsmolecular informatics softwarescientific consultingscreening library design

Atelier Therapeutics is a biopharmaceutical company dedicated to advancing human health through innovative approaches, with a primary focus on under-explored GPCR drug targets. Leveraging expertise in structural biology, computational chemistry, and machine learning, the team develops differentiated therapies addressing major unmet medical needs, focused on reducing chronic inflammation and enhancing neuronal function to promote vitality and longevity.

computational chemistrydrug discoverymachine learning

Atomic AI operates at the intersection of artificial intelligence and RNA therapeutics, using machine learning and structural biology to develop RNA-centric medicines. Its proprietary R&D platform leverages ATOM-1, a foundation model for RNA that delivers precise predictions of RNA structure and function, integrated with in-house wet-lab assays. The company focuses on designing foundation models for RNA and developing RNA-targeted small molecules and RNA-based therapeutics.

drug discoverymachine learningmedicinal chemistryRNA structure and function predictionwet-lab assays

BioAscent is a provider of integrated drug discovery services based at the former Organon/MSD R&D site in Newhouse, Scotland, UK. Founded in 2013, its services include assay development, target analysis, compound screening, medicinal and synthetic chemistry, computational chemistry, DMPK, protein science and compound management, with access to in-house diversity and fragment libraries.

assay developmentbiophysicscompound managementcompound screeningcompound storage and logisticscomputational chemistryDMPKhigh-throughput screeningin silico discoveryLC-MSliquid handlingmedicinal chemistryNMRprotein productionpurificationsurface plasmon resonancesynthetic chemistry

ConquestBio is a Drug Discovery and Development company registered in Delaware with operations in Florida. It applies structural biology, computational biology, AI, ML and GenAI to design and discover safe and efficacious small molecule drugs at scale, focusing on biologically and clinically validated molecular targets. Its GenAI-driven platform integrates biology and pharmacology to design drugs that inhibit protein-protein interactions driving serious diseases.

AI-based drug designcomputational biologyGenAI modelingmachine learningsmall molecule drug discovery

The European Molecular Biology Laboratory (EMBL) is an intergovernmental organisation headquartered in Heidelberg, founded in 1974 with the mission of promoting molecular biology research in Europe, training young scientists, and developing new technologies. Supported by more than 30 countries, it operates six sites in Barcelona, Grenoble, Hamburg, Heidelberg, EMBL-EBI Hinxton, and Rome, employing more than 1800 people and hosting more than 110 independent research groups and service teams.

bioinformaticschemical biologyelectron microscopyflow cytometrygenomicshigh-throughput crystallisationimagingin vivo gene editingIT serviceslight microscopymetabolomicsmobile laboratory servicesprotein expression and purificationproteomicsscientific instrumentation workshopsX-ray beamlines